1.Arababadi MK, Naghavi N, Hassanshahi G, Mahmoodi M. CCR5 A 32 mutations is associated with nephropathies of type 2 diabetes Ann Saudi Med (article in press).
2.Nosratabadi R, Arababadi MK, Hassanshahi G, Yaghini N, Pooladvand V, Shamsizadeh A. Evaluation of IFN-y serum level in nephropatic type 2 diabetic patients. Pak J Biol Sci 2009; 12:746-749.
3.Skopinski P, Rogala E, Duda-Krol B, Lipinska A, Sommer E, Chorostowska-Wynimko J, et al. Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. J Diabetes Complications 2005; 19:335-338.
4.Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol 2005; 65:171-8.
5.Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: A study in the north Indian population. Indian J Med Sci 2008; 62:259-266.
6.Stalenhoef JE, Alisjahbana B, Nelwan EJ, Van der Ven-Jongekrijg J, Ottenhoff TH, Van der Meer JW, et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2008; 27:97-103.
7.Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN- gamma production. Hum Immunol 2000; 61:863-366.
8.Daneshmandi S, Pourfathollah A, Arababadi MK, Hassanshahi G, Rezaeian M, Asiabanha M. Evaluation of relation between IL-4 and IFN-y polymorphisms and type 2 diabetes. J Mazand Univ Med Sci 2008; 18:35-41.
9.Tsiavou A, Hatziagelaki E, Chaidaroglou A, Koniavitou K, Degiannis D, Raptis SA. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 2005; 31:135-41.
10.Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2008; 82:329-34.
11.Rasouli M, Kiany S. Association of interferon-gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine 2007; 38:49-53.
12.Kamali-Sarvestani E, Rasouli M, Mortazavi H, Gharesi-Fard B. Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 2006; 35:159-165.
13.Sallakci N, Coskun M, Berber Z, Gurkan F, Kocamaz H, Uysal G, et al. Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis 2007; 87:225-230.
14.Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A, et al. Associations between the IL-4 -590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Microbes Infect 2007; 9:1043-1048.
15.Hanck C, Schneider A, Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Best Pract Res Clin Gastroenterol 2003; 17:613-623.
16.Rafinejad A, Niknam MH, Amirzargar AA, Khosravi F, Karimi F, Larijani B. Association of IFN-1 gene polymorphism with type 1 diabetes in Iranian patients. Iran J Immunol 2004; 1:130-132.